Abstract P3-04-07: The new oral SERD AZD9496 is efficacious in antagonizing ER and circumventing resistance to endocrine therapy

Agostina Nardone, Rachel Schiff, C. Kent Osborne et al.|Cancer Research|2017

Cited by 0